Neuren Pharmaceuticals | NEU - Gross Profit On Sales


Neuren Pharmaceuticals reported AUD6.69M in Gross Profit on Sales for its fiscal semester ending in June of 2025.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 47.28M 1.7M Dec/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Avita Medical AUD 14.31M 639K Dec/2025
Clinuvel Pharmaceuticals AUD 57.82M 18.86M Jun/2024
Dianthus Therapeutics USD 463K 179K Mar/2026
Genetic Signatures AUD 4.75M 190K Dec/2024
Ionis Pharmaceuticals USD 265M 22M Jun/2026
Medical Developments International AUD 7.35M 7.37M Jun/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Organon & Co USD 847M 64M Jun/2026
Paradigm Biopharmaceuticals AUD -9K 423.94K Jun/2025
PYC Therapeutics AUD 5.83M 750K Jun/2025
Starpharma Holdings AUD -736K 2.82M Jun/2025
Tectonic Therapeutic USD 0 0 Mar/2025
Telix Pharmaceuticals AUD 260.35M 42.53M Jun/2026
Viatris USD 1.57B 193.9M Jun/2026
Xeris Pharmaceuticals USD 72.55M 404K Mar/2026